The study will determine the efficacy of the cells to treat rotator cuff tears necessitating arthroscopic repair.
Pluristem has also announced that PLX-PAD cells are intended to grow the company’s presence in the sports medicine and orthopedic markets.
More Articles on Sports Medicine:
Manhattan Orthopedic Care Releases NBA Injury Infographic
Drs. Robert Zura, Claude Moorman Perform Successful Surgery on Duke’s Seth Curry
Methodist Willowbrook Hospital Opens Sports Medicine Center
